Importance of zinc in cystic fibrosis patients

Current Pediatric Reviews

Volumn 5, Issue 3, 2009, Pages 184-188

  Van Biervliet, Stephanie ^a   Van Biervliet, Jean Pierre ^b   Robberecht, Eddy ^b   Taylor, Chris ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cystic fibrosis; Fatty acids; Growth; Immunity; Oxidative stress; Zinc

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; ARACHIDONIC ACID; B LYMPHOCYTE ANTIBODY; CHLORIDE; ESSENTIAL FATTY ACID; LINOLEIC ACID; PHOSPHOLIPASE A2; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; THYMULIN; ZINC;

BINDING AFFINITY; CALORIC INTAKE; CHLORIDE TRANSPORT; CYSTIC FIBROSIS; DECREASED APPETITE; DIET SUPPLEMENTATION; ESSENTIAL FATTY ACID DEFICIENCY; GROWTH DISORDER; HUMAN; IMMUNE DEFICIENCY; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TASTE DISORDER; ZINC BLOOD LEVEL; ZINC DEFICIENCY; ZINC METABOLISM;

EID: 70350596109     PISSN: 15733963     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339609789007222     Document Type: Review

References (91)

1. Sandström B, Arvidsson B, Cederblad A, Björn-Rasmussen E. Zinc absorption from composite meals. The significance of wheat extraction rate, zinc calcium and protein content in meals based on bread. Am J Clin Nutr 1980; 33: 739-745 (Pubitemid 10077659)
2. Krebs NF. Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr 2000; 130: 1374S-7S.
3. Condomina J, Zornoza-Sabina T, Granero L, Polache A. Kinetics of zinc transport in vitro in rat small intestine and colon: Interaction with Cu. Eur J Pharm Sci 2002; 16: 289-295
4. Brewer GJ. Zinc acetate for the treatment of Wilson's disease. Exp Opin Pharmacother 2001; 2: 1473-1477
5. King JC, Shames DM, Woodhouse LR. Zinc homeostasis in humans. J Nutr 2000; 130: 1360S-6S.
6. Victery W, Smith JM, Vander AJ. Renal tubular handling of zinc in the dog. Am J Physiol 1981; 241: 532-539 (Pubitemid 12242574)
7. Sekler I, Sensi SL, Hershfinkel M, Silverman WF. Mechanism and regulation of cellular zinc transport. Mol Med 2007; 13: 337-343 (Pubitemid 47378133)
8. Kambe T, Ymaguchi-Iwai Y, Sasaki R, Nagao M. Overview of mammalian zinc transporters. Cell Mol Life Sci 2004; 61: 49-68.
9. De Lisle RC, Sarras Jr MP, Hidalgo J, Andrews GK. Metallothioneins a component of exocrine pancreas secretion: implications for zinc homeostasis. Am J Physiol 1996; 271: C1103-10. (Pubitemid 126757708)
10. Van Wouwe JP, Uijlenbroek JJM. The role of the pancreas in the regulation of Zinc status. Biol Trace Elem Res 1994; 42: 143-149
11. Wang K, Zhou B, Kuo YM, Zemansky J, Gitschier J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am J Hum Genet 2002; 71: 66-73. (Pubitemid 34734708)
12. Liuzzi JP, Blanchard RK, Cousins RJ. Differential regulation of the zinc transporter 1, 2 and 4 mRNA expression by dietary zinc in rats. J Nutr 2001; 131: 46-52. (Pubitemid 32060621)
13. Krebs NF, Westcott JE, Arnold TD, et al. Abnormalities in Zinc homeostasis in young infants with cystic fibrosis. Pediatr Res 2000; 48: 256-261
14. Easley D, Krebs N, Jefferson M, et al. Effect of pancreatic enzymes on Zinc absorption in cystic fibrosis. J Pediatr Gastroenterol Nutr 1998; 26: 136-139 (Pubitemid 28078474)
15. Kalivianakis M, Minich DM, Bijleveld CMA, et al. Fat absorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 1999; 69: 127-134 (Pubitemid 29031262)
16. Hambidge M. Biomarkers of trace mineral intake and status. J Nutr 2003; 133: 948-955
17. Hess SY, Peerson JM, King JC, Brown KH. Use of serum zinc concentration as an indicator of population zinc status. Food Nutr Bull 2007; 28: 403-429
18. Wallock LM, King JC, Hambidge KM, English-Wescott JE, Pritts J. Meal-induced changes in plasma, erythrocyte and urinary zinc concentrations in adult women. Am J Clin Nutr 1993; 58: 695-701. (Pubitemid 23319958)
19. Hotz C, Peerson JM, Brown KH. Suggested lower cutoffs of serum zinc concentrations for assessing zinc status: Reanalysis of the second National Health and Nutrition Examination Survey data (1976-1980). Am J Clin Nutr 2003; 78: 756-764
20. Thurnham DI, Mburu AS, Mwaniki DL, De Wagt A. Micronutrients in childhood and the influence of subclinical inflammation. Proc Nutr Soc 2005; 64: 502-509 (Pubitemid 41705452)
21. Van Biervliet S, Van Biervliet JP, Bernard D, Vercaemst R, Blaton V. Serum zinc in healthy belgian children. Biol Trace Elem Res 2003; 94: 33-40. (Pubitemid 36980633)
22. Aklani L, Lowenthal DB, Gjonaj S, Dozor AJ. Plasma and red blood cell zinc in cystic fibrosis. Pediatr Pulmonol 2003; 35: 2-7. (Pubitemid 36009006)
23. Maqbool A, Schall JI, Zemel BS, Garcia-Espana JF, Stallings VA. Plasma zinc and growth status in preadolescent children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2006; 43: 95-101. (Pubitemid 44022393)
24. Van Biervliet S, Van Biervliet JP, Robberecht E. Serum zinc in patients with cystic fibrosis at diagnosis and after one year therapy. Biol Trace Elem Res 2006; 112: 205-212 (Pubitemid 44624060)
25. Van Biervliet S, Van Biervliet JP, Vande Velde S, Robberecht E. Serum zinc concentrations in cystic fibrosis patients with ages above four years: A cross-sectional evaluation. Biol Trace Elem Res 2007; 119: 19-26. (Pubitemid 47585010)
26. Van Caillie-Bertrand M, Debieville M, Neijens H, Kerrebijn K, Fernandez J, Degenhart H. Trace elements in cystic fibrosis. Acta Paediatr Scand 1982; 71: 203-207
27. Crone J, Huber WD, Eichler I, Granditsch G. Acrodermatitis enteropathica-like eruption as the presenting sign of cystic fibrosis. Case report and review of the literature. Eur J Pediatr 2002; 161: 475-478 (Pubitemid 35013666)
28. Darmstadt GL, McGuire J, Ziboh VA. Malnutrition associated rash of cystic fibrosis. Pediatr Dermatol 2000; 17: 337-347 (Pubitemid 30822729)
29. Martin DP, Tangsinmankong N, Sleasman JW, Day-good NK, Wongchantara DR. Acrodermatitis enteropathica-like eruption and food allergy. Ann Allergy Asthma Immunol 2005; 94: 398-401. (Pubitemid 40396588)
30. Krebs NF, Westcott JE, Arnold TD, et al. Abnormalities in Zinc homeostasis in young infants with cystic fibrosis. Pediatr Res 2000; 48: 256-261
31. Chester JK, Quaterman J. Effects of zinc deficiency on food intake and feeding pattern of rats. Br J Nutr 1970; 24: 1061-1069
32. Paski SC, Xu Z. Labile intracellular zinc is associated with 3T3 cell growth. J Nutr Biochem 2001; 12: 655-661 (Pubitemid 33036875)
33. Yu Z-P, Le G-W, Shi Y-H. Effect of zinc sulphate and zinc methionine on growth, plasma growth hormone concentration, growth hormone receptor and insulin-like growth factor-I gene expression in mice. Clin Exp Pharmacol Phys 2005; 32: 273-278
34. Brown KH, Peerson JM, Rivera J, Allen LH. Effect of supplemental zinc on the growth and serum zinc concentrations of prepubertal children: A meta-analysis of randomized controlled trials. Am J Clin Nutr 2002; 75: 1062-1071 (Pubitemid 34547537)
35. Krebs NF, Hambidge KM, Walravens PA. Increased food intake of young children receiving a zinc supplement. Am J Dis Child 1984; 138: 270-273
36. Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European consensus. J Cyst Fibros 2002; 1: 51-57
37. Moudiou T, Galli-Tsinopoulou A, Vamvakoudis E, Nousiaarvanitakis S. Resting energy expenditure in cystic fibrosis as an indicator of disease severity. J Cyst Fibros 2007; 6: 131-136 (Pubitemid 46381654)
38. Taylor AM, Thomson A, Bruce-Morgan C, et al. The relationship between insulin, IGF-I and weight gain in cystic fibrosis. Clin Endocrinol 1999; 51: 659-665
39. Van Biervliet S, Vande Velde S, Van Biervliet JP, Robberecht E. The effect of zinc supplements in cystic fibrosis patients. Ann Nutr Metab 2008; 52: 152-156 (Pubitemid 351723136)
40. Cunnane SC, Krieger I. Long chain fatty acids in serum phospholipids in acrodermatitis enteropathica before and after zinc treatment: A case report. J Am Coll Nutr 1988; 7: 249-250 (Pubitemid 18212500)
41. Krieger I, Alpern BE, Cunnane SC. Transient neonatal zinc deficiency. Am J Clin Nutr 1986; 43: 955-958
42. Mack D, Koletzko B, Cunnane S, Cutz E, Griffiths A. Acrodermatitis enteropathica with normal serum zinc levels: Diagnostic value of small bowel biopsy and essential fatty acid determination. Gut 1989; 30: 1426-1429 (Pubitemid 19270155)
43. Cunnane SC, Horrobin DF, Manku MS. Essential fatty acids in tissue phospholipids and triglycerides of the zinc-deficient rat. Proc Soc Exp Biol Med 1984; 177: 441-446 (Pubitemid 15184378)
44. Cunnane SC. Maternal essential fatty acid supplementation increases zinc absorption in neonatal rats: relevance to the defect in zinc absorption in acrodermatitis enteropathica. Pediatr Res 1982; 16: 599-603.
45. Cunnane SC, Yang J. Zinc deficiency impairs whole-body accumulation of polyunsaturates and increases the utilisation of [1-14C] Linoleate for de novo synthesis in pregnant rats. Can J Physiol Pharmacol 1995; 73: 1246-1252
46. Eder K, Kirchgessner M. Dietary fat influences the effect of zinc deficiency on liver lipids and fatty acids in rats force-fed equal quantities of diet. J Nutr 1994; 124: 1917-1926 (Pubitemid 24334626)
47. Eder K, Kirchgessner M. Activities of liver microsomal fatty acid desaturases in zinc-deficient rats force-fed diets with a coconut oil/safflower oil mixture of linseed oil. Biol Trace Elem Res 1995; 48: 215-229
48. Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlstörm J. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 2001; 139: 650-655 (Pubitemid 33097428)
49. Van Biervliet S, Vanbillemont G, Van Biervliet JP, Declercq D, Robberecht E, Christophe A. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients. Ann Nutr Metab 2007; 51: 541-549 (Pubitemid 351315920)
50. Roulet M, Frascarolo P, Rappaz I, Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr 1997; 156: 952-956 (Pubitemid 28006316)
51. Carlstedt-Duke J, Brönnegard M, Strandvik B. Pathological regulation of arachidonic acid release in cystic fibrosis: The putative basic defect. Proc Natl Acad Sci USA 1986; 83: 9202-9206 (Pubitemid 17223563)
52. Levistre R, Lemnaouar M, Rybkine T, Bereziat G, Masliah J. Increase of bradykinin stimulated arachidonic acid release in a delta-F508 cystic fibrosis epithelial cell line. Biochim Biophys Acta 1993; 1181: 233-239 (Pubitemid 23177213)
53. Rogiers V, Dab I, Michotte Y, Vercruysse A, Crockaert R, Vis HL. Abnormal fatty acid turnover in the phospholipids of the red blood cell membranes of cystic fibrosis patients (in vitro study). Pediatr Res 1984; 18: 704-709
54. Hamilton RM, Gillespie CT, Cook HW. Relationships between levels of essential fatty acids and zinc in plasma of cystic fibrosis patients. Lipids 1981; 16: 374-376
55. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci USA 1999; 96: 13995-40000.
56. Harada T, Koyama I, Matsunaga T, et al. Characterisation of structural and catalytic differences in rat intestinal alkaline phosphatase isozymes. FEBS J 2005; 272: 2477-2486 (Pubitemid 40705068)
57. Malo MS, Mozumder M, Zhang XB, et al. Intestinal alkaline phosphatase gene expression is activated by ZBP-89. Am J Physiol Gastrointest Liver Physiol 2006; 290: 737-746
58. Goldberg RF, Austen WG, Zhang X, et al. Intestinal alkaline phosphatase is a gut mucosal defence factor maintained by enteral nutrition. Proc Natl Acad Sci USA 2008; 105: 3551-3556 (Pubitemid 351723590)
59. Dudeja PK, Brasitus TA. Inactivation of rat smaal intestinal brush-border membrane alkaline phosphatase by oxygen free radicals. Gastroenterology 1993; 105: 357-366
60. Van Biervliet S, Eggermont E, Carchon H, Veereman G, Deboeck K. Small intestinal brush border enzymes in cystic fibrosis. Acta Gastroenterol Belg 1999; 62: 267-271 (Pubitemid 29472854)
61. Van Biervliet S, Eggermont E, Marien P, Hoffman I, Veereman G. Combined impact of mucosal damage and of cystic fibrosis on the small intestinal brush border enzyme activities. Acta Clin Belg 2003; 58: 220-224 (Pubitemid 37339143)
62. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 2007; 44: 212-218 (Pubitemid 46175075)
63. Prasad AS, Meftah S, Abdallah J, et al. Serum thymulin in human deficiency. J Clin Invest 1988; 82: 1202-1210
64. Brazova J, Sediva A, Pospisilova D, et al. Differential cytokine profile in children with cystic fibrosis. Clin Immunol 2005; 115: 210-215 (Pubitemid 40703901)
65. Depasquale-Jardieu P, Fraker PJ. Interference in the development of a secondary immune response in mice by zinc deprivation: Persistence of effects. J Nutr 1984; 114: 1762-1769
66. Sediva A, Vavrova V, Bartosova J, et al. Immune aspects of cystic fibrosis. Allergy Clin Immunol Int 2001; 13: 67-70.
67. Shankar AJ, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 1998; 68: S447-63.
68. Mocchegiani E, Provinciali M, Di Stefano G, et al. Role of the low zinc bioavailability on cellular immune effectiveness in cystic fibrosis. Clin Immun Immunopathol 1995; 75: 214-224
69. 2-macroglobulin. Pediatr Res 1982; 16: 416-423
70. Chakavis T, May AE, Preissner KT, Kanse SM. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and B2-integrins. Blood 1999; 93: 2976-2983
71. Hujanen ES, Seppä ST, Virtanen K. Polymorpohnuclear leukocyte chemotaxis induced by zinc, copper and nickel in vitro. Biochim Biophys Acta 1995; 1245: 145-152
72. Allen JL, Perri RT, McClain CJ, Kay NE. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med 1983; 102: 577-589
73. Knutsen AP, Slavin RG, Roodman ST, Mueller KR, Marino NL. Decreased T-helper cell function in patients with cystic fibrosis. Int Arch Allergy Appl Immunol 1988; 85: 208-212
74. Knutsen AP, Muller KR. T-Cell cytotoxicity in cystic fibrosis relation to pulmonary status. Int Arch Allergy Appl Immunol 1990; 93: 54-58
75. Langkamp-Henken B, Bender BS, Gardner EM, et al. Nutritional formula enhanced immune function and reduced days of symptoms of upper respiratory tract infection in seniors. J Am Geriatr Soc 2004; 52: 3-12. (Pubitemid 38090383)
76. Sazawal S, Black RE, Bhan MK, Bhandari N, Sinha A, Jalla S. Zinc supplementation in young children with acute diarrhoea in India. New Engl J Med 1995; 333: 839-844
77. Sazawal S, Black R, Jalla S, Mazumdar S, Sihna A, Bhan MK. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: A double blind placebo controlled trial. Pediatrics 1998; 102: 1-5. (Pubitemid 28309237)
78. Abdulhamid I, Beck FW, Millard S, Chen X, Prasad A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatr Pulmonol 2008; 43: 281-287
79. Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol 1995; 42: 551-556
80. Wellinghausen N, Fischer A, Kirchner H, Rink L. Interaction of zinc ions with human peripheral blood mononuclear cells. Cell Imunol 1996; 171: 255-261 (Pubitemid 26268482)
81. Gomez NN, Fernandez MR, Zirulnik F, Gil E, et al. Chronic zinc deficiency induces an antioxidant adaptive response in rat lung. Exp Lung Res 2003; 29: 485-502. (Pubitemid 37255447)
82. Tapiero H, Tew KD. Trace elements in human physiology and pathology: Zinc and metallothioneins. Biomed Pharmacother 2003; 57: 399-411. (Pubitemid 37498214)
83. Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AE. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995; 61: 843-847
84. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients. Am J Clin Nutr 2002; 75: 668-675
85. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML. Oxidative stress in cystic fibrosis: Dietary and metabolic factors. J Am Coll Nutr 2001; 20: 157-165
86. Brown RK, Kelly J. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res 1994; 36: 487-493 (Pubitemid 24289786)
87. Benabdeslam H, Abidi H, Garcia I, Bellon G, Gilly R, Revol A. Lipid peroxidation and antioxidant defences in cystic fibrosis patients. Clin Chem Lab Med 1999; 37: 511-516 (Pubitemid 29304414)
88. Percival SS, Kauwell GP, Bowser E, Wagner M. Altered copper status in adult men with cystic fibrosis. J Am Coll Nutr 1999; 18: 614-619 (Pubitemid 30010742)
89. Percival SS, Bowser E, Wagner M. Reduced copper enzyme activities in blood cells of children with cystic fibrosis. Am J Clin Nutr 1995; 62: 633-638
90. Zsembery A, Fortenberry JA, Liang L, et al. Extracellular zinc and ATP restore chloride secretion across cystic fibrosis airway epithelia by triggering calcium entry. J Biol Chem 2004; 279: 10720-10729 (Pubitemid 38372685)
91. Safai-Kutti S, Selin E, Larsson S, et al. Zinc therapy in children with cystic fibrosis. Beitr Infusionsther 1991; 27: 104-114